Unicycive Therapeutics Inc. (NASDAQ: UNCY)
$0.49
N/A ( 0% ) 492.5K
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's lead drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury.
Market Data
Open
$0.49
Previous close
$0.49
Volume
492.5K
Market cap
$42.75M
Day range
$0.48 - $0.50
52 week range
$0.34 - $1.82
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 14 | Nov 14, 2023 |
10-q | Quarterly Reports | 73 | Nov 14, 2023 |
8-k | 8K-related | 14 | Oct 23, 2023 |
8-k | 8K-related | 12 | Sep 25, 2023 |
4 | Insider transactions | 1 | Sep 07, 2023 |
4 | Insider transactions | 1 | Sep 07, 2023 |
4 | Insider transactions | 1 | Sep 07, 2023 |
4 | Insider transactions | 1 | Sep 07, 2023 |
3 | Insider transactions | 1 | Sep 07, 2023 |
8-k | 8K-related | 14 | Sep 06, 2023 |